FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783013669> ?p ?o ?g. }

• W2783013669 endingPage "255" @default.
• W2783013669 startingPage "250" @default.
• W2783013669 abstract "Purpose: The purpose of this study was to evaluate the clinical efficacy and safety of a novel ophthalmic solution of pazufloxacin on the ocular surface of patients with bacterial conjunctivitis after 7 days of intervention. Methods: This is a phase 2, double-blind, controlled, multicenter, clinical trial of 300 subjects, randomized to either a 3 dosing regimen of pazufloxacin 0.6% ophthalmic solution (twice a day [BID], n = 90; 3 times a day [TID], n = 76; 4 times a day [QID], n = 68), moxifloxacin 0.5% TID (n = 82), or gatifloxacin 0.3% TID (n = 72). Follow-up was set on days 0, 3, and 7. Assessments of ocular signs were performed, both anterior and posterior segments. The primary outcome measures included conjunctival culture and clinical signs. Safety variables included adverse events (AEs), lisamine green, fluorescein ocular surface stains, and clinical signs of tolerability. Results: After intervention, bacterial eradication was reported in all groups: pazufloxacin BID 79%, pazufloxacin TID 84%, pazufloxacin QID 84%, moxifloxacin 80%, and gatifloxacin 82%. There were no significant differences between treatments. Similar results were reported in clinical remission: pazufloxacin BID 89%, pazufloxacin TID 98%, pazufloxacin QID 92%, moxifloxacin 91%, and gatifloxacin 92% (P = 0.03 comparing pazufloxacin BID vs. TID). There were no differences between female and male responses. The AEs were not related to the interventions. Conclusions: A simplified dosing regimen was selected to follow the development of ophthalmic pazufloxacin based on its efficacy and safety profile. Pazufloxacin, 1 drop 3 times daily, showed similar rates of bacterial eradication and clinical remission compared with other fluoroquinolones." @default.
• W2783013669 created "2018-01-26" @default.
• W2783013669 creator A5016476418 @default.
• W2783013669 creator A5021512769 @default.
• W2783013669 creator A5027447207 @default.
• W2783013669 creator A5031896392 @default.
• W2783013669 creator A5031939021 @default.
• W2783013669 creator A5034182887 @default.
• W2783013669 creator A5035734789 @default.
• W2783013669 creator A5037013328 @default.
• W2783013669 creator A5039457335 @default.
• W2783013669 creator A5043201561 @default.
• W2783013669 creator A5062529728 @default.
• W2783013669 creator A5066203365 @default.
• W2783013669 creator A5069728046 @default.
• W2783013669 creator A5070455014 @default.
• W2783013669 creator A5075268263 @default.
• W2783013669 creator A5079403263 @default.
• W2783013669 creator A5085634460 @default.
• W2783013669 date "2018-04-01" @default.
• W2783013669 modified "2023-09-27" @default.
• W2783013669 title "Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial" @default.
• W2783013669 cites W108399861 @default.
• W2783013669 cites W1589822958 @default.
• W2783013669 cites W1990480280 @default.
• W2783013669 cites W2000441785 @default.
• W2783013669 cites W2003762306 @default.
• W2783013669 cites W2012921948 @default.
• W2783013669 cites W2033851196 @default.
• W2783013669 cites W2058754088 @default.
• W2783013669 cites W2067852897 @default.
• W2783013669 cites W2075175082 @default.
• W2783013669 cites W2077684968 @default.
• W2783013669 cites W2090726997 @default.
• W2783013669 cites W2097897268 @default.
• W2783013669 cites W2102055645 @default.
• W2783013669 cites W2103707128 @default.
• W2783013669 cites W2109363737 @default.
• W2783013669 cites W2118013305 @default.
• W2783013669 cites W2121204035 @default.
• W2783013669 cites W2124899117 @default.
• W2783013669 cites W2134759355 @default.
• W2783013669 cites W2139297286 @default.
• W2783013669 cites W2150290224 @default.
• W2783013669 cites W2167275970 @default.
• W2783013669 cites W2179818990 @default.
• W2783013669 cites W4234779161 @default.
• W2783013669 doi "https://doi.org/10.1089/jop.2017.0056" @default.
• W2783013669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29624493" @default.
• W2783013669 hasPublicationYear "2018" @default.
• W2783013669 type Work @default.
• W2783013669 sameAs 2783013669 @default.
• W2783013669 citedByCount "4" @default.
• W2783013669 countsByYear W27830136692019 @default.
• W2783013669 countsByYear W27830136692020 @default.
• W2783013669 countsByYear W27830136692021 @default.
• W2783013669 countsByYear W27830136692022 @default.
• W2783013669 crossrefType "journal-article" @default.
• W2783013669 hasAuthorship W2783013669A5016476418 @default.
• W2783013669 hasAuthorship W2783013669A5021512769 @default.
• W2783013669 hasAuthorship W2783013669A5027447207 @default.
• W2783013669 hasAuthorship W2783013669A5031896392 @default.
• W2783013669 hasAuthorship W2783013669A5031939021 @default.
• W2783013669 hasAuthorship W2783013669A5034182887 @default.
• W2783013669 hasAuthorship W2783013669A5035734789 @default.
• W2783013669 hasAuthorship W2783013669A5037013328 @default.
• W2783013669 hasAuthorship W2783013669A5039457335 @default.
• W2783013669 hasAuthorship W2783013669A5043201561 @default.
• W2783013669 hasAuthorship W2783013669A5062529728 @default.
• W2783013669 hasAuthorship W2783013669A5066203365 @default.
• W2783013669 hasAuthorship W2783013669A5069728046 @default.
• W2783013669 hasAuthorship W2783013669A5070455014 @default.
• W2783013669 hasAuthorship W2783013669A5075268263 @default.
• W2783013669 hasAuthorship W2783013669A5079403263 @default.
• W2783013669 hasAuthorship W2783013669A5085634460 @default.
• W2783013669 hasConcept C126322002 @default.
• W2783013669 hasConcept C141071460 @default.
• W2783013669 hasConcept C168563851 @default.
• W2783013669 hasConcept C197934379 @default.
• W2783013669 hasConcept C2777288759 @default.
• W2783013669 hasConcept C2777653605 @default.
• W2783013669 hasConcept C2778375690 @default.
• W2783013669 hasConcept C2778836808 @default.
• W2783013669 hasConcept C2781276175 @default.
• W2783013669 hasConcept C2781413609 @default.
• W2783013669 hasConcept C501593827 @default.
• W2783013669 hasConcept C535046627 @default.
• W2783013669 hasConcept C71924100 @default.
• W2783013669 hasConcept C86803240 @default.
• W2783013669 hasConcept C89423630 @default.
• W2783013669 hasConceptScore W2783013669C126322002 @default.
• W2783013669 hasConceptScore W2783013669C141071460 @default.
• W2783013669 hasConceptScore W2783013669C168563851 @default.
• W2783013669 hasConceptScore W2783013669C197934379 @default.
• W2783013669 hasConceptScore W2783013669C2777288759 @default.
• W2783013669 hasConceptScore W2783013669C2777653605 @default.
• W2783013669 hasConceptScore W2783013669C2778375690 @default.
• W2783013669 hasConceptScore W2783013669C2778836808 @default.

• next